Näslund, Erik http://orcid.org/0000-0002-4989-1831
Lindberg, Lars-Göran http://orcid.org/0000-0002-7912-2697
Strandberg, Gunnar http://orcid.org/0000-0003-4959-6389
Apelthun, Catharina
Franzén, Stephanie http://orcid.org/0000-0002-5003-2508
Frithiof, Robert http://orcid.org/0000-0003-2278-7951
Funding for this research was provided by:
Vetenskapsrådet (2014-02569)
Uppsala University
Uppsala University
Article History
Received: 8 June 2022
Accepted: 29 January 2023
First Online: 14 February 2023
Declarations
:
: Lars-Göran Lindberg is a co-owner of a development company, RespiHeart AB, with the intent of commercialisation of the RespiHeart system, used in the current study. The remaining authors have no conflicts of interest to declare that are relevant to the content of this article.
: The Animal Ethics Committee of Uppsala University, Sweden, approved the experiment (5.8.18–02325/2019, date of approval 2019-03-29). All animals were treated according to the Swedish Board of Agriculture guidelines and complied with the European Convention for the Protection of Vertebrate Animals used for Experimental and other Scientific Purposes (Council of Europe No 123, Strasbourg 1985).
: Not applicable.
: Not applicable.